Home > World > BRIEF-Natera Inc Says IMvigor011 Trial Achieves 41% Improvement In Overall Survival

BRIEF-Natera Inc Says IMvigor011 Trial Achieves 41% Improvement In Overall Survival

Last Updated: October 20, 2025 12:26:56 IST

Oct 20 (Reuters) – Natera Inc: * NATERA INC: SUCCESSFUL IMVIGOR011 TRIAL ACHIEVES 41% IMPROVEMENT IN OVERALL SURVIVAL FOR BLADDER CANCER PATIENTS Source text: Further company coverage:

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)

Most Popular

The Sunday Guardian is India’s fastest
growing News channel and enjoy highest
viewership and highest time spent amongst
educated urban Indians.

The Sunday Guardian is India’s fastest growing News channel and enjoy highest viewership and highest time spent amongst educated urban Indians.

© Copyright ITV Network Ltd 2025. All right reserved.

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?